Financial Daily from THE HINDU group of publications
Thursday, Jun 02, 2005
Financial Daily from THE HINDU group of publications Thursday, Jun 02, 2005 |
|
|
|
|
|
Corporate
-
New Products & Services German Remedies launches injection for multiple sclerosis Our Bureau
Mumbai , June 1 BETAFERON, a subcutaneous injection of Interferon used in the treatment of multiple sclerosis, has been launched in India by German Remedies. Part of the Zydus Group, German Remedies has launched Interferon beta-1b under the brand name `Betaferon'. The injection is the only Interferon efficacious even in the secondary progressive stages of multiple sclerosis, a German Remedies communication said. The product is being marketed in collaboration with Schering AG, Germany. Multiple sclerosis is a chronic degenerative disease of the central nervous system and occurs largely in young adults from 20 to 50 years. It results in patients slowly losing control over their bodies, the note said. Betaferon was launched in the US in 1993. According to estimates, 1.5 million people suffer from multiple sclerosis worldwide. Betaferon is the top global product of Schering AG with over 2,00,000 patients on this treatment worldwide, the note added.
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2005, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|